Indegene, a digital-first life sciences commercialization company, has been recognized as one of the standout winners of Deloitte Private's Enterprise Growth Awards 2025. The awards acknowledged Indegene's commitment to its purpose of enabling healthcare organizations to be future-ready, its robust corporate governance practices and sustained growth.
Enterprise Growth Awards is a unique programme by Deloitte Private dedicated to celebrating businesses that have transformed local ambitions into national and global success stories. These awards showcase inspiring stories of businesses that have built lasting legacies while maintaining sustainable growth trajectories and aim to inspire the next generation of entrepreneurs.
The awardees underwent a robust evaluation process before being selected as winners. A distinguished jury panel of industry leaders, comprising S. D. Shibulal, Former Managing Director, Infosys and Chairperson of the jury panel; Dr. Brinda Jagirdar, Former Chief Economist of the State Bank of India and Independent Director; M. D. Ranganath, Chairman, Catamaran Ventures and Board Member of HDFC; and Manoj Kohli, International Growth Advisor to MNCs and Global Funds and Business Transformation Coach, assessed the participating companies.
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. Its client base includes the world's top 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has about 5,000 employees worldwide, 6 operation hubs and 18 offices across North America, Europe, and Asia.
Shares of Indegene Limited was last trading in BSE at Rs. 534.50 as compared to the previous close of Rs. 526.30. The total number of shares traded during the day was 17721 in over 781 trades.
The stock hit an intraday high of Rs. 550.00 and intraday low of 525.55. The net turnover during the day was Rs. 9536865.00. |
